This inventor holds 1 USPTO granted patent. Top assignee: Emory University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Thomas Kaiser: Innovator in Neurodegenerative Disease Treatment
Introduction
Thomas Kaiser is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. His innovative work focuses on developing compounds that target specific proteins involved in these conditions.
Latest Patents
Thomas Kaiser holds a patent for "Abelson non-tyrosine kinase compounds for the treatment of neurodegenerative diseases." This patent relates to compounds designed for treating various neurological disorders, including Parkinson's disease and Alzheimer's disease. The compounds specifically target the Abelson non-tyrosine kinase (c-Abl) protein, offering new avenues for treatment.
Career Highlights
Kaiser is affiliated with Emory University, where he conducts research and develops his innovative ideas. His work has garnered attention for its potential impact on the treatment of debilitating neurological conditions.
Collaborations
Some of his notable coworkers include Zackery Will Dentmon and Christopher Dalloul. Their collaborative efforts contribute to the advancement of research in neurodegenerative diseases.
Conclusion
Thomas Kaiser is a key figure in the development of treatments for neurodegenerative diseases, with a focus on innovative compounds targeting the c-Abl protein. His contributions are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile